Nurix Therapeutics is Part of a Team of International Oncology Experts Selected as Cancer Grand Challenges Awardees to Address Pediatric Cancers Using Targeted Protein Degradation (TPD)
25 mars 2024 07h00 HE
|
Nurix Therapeutics, Inc.
Researchers will apply the latest TPD drug discovery technology to target fusion proteins that cause pediatric cancer Cancer Grand Challenges is an initiative funded by Cancer Research UK SAN...
Vascular access device Market Size Worth USD 10.90 Billion in 2032 | Emergen Research
29 janv. 2024 11h00 HE
|
Emergen Research
Vancouver, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The global vascular access device market size was USD 5.45 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.1% during the forecast...
High Intra-Tumor TGF-β2 Predicts Poor Survival in Pediatric Cancer of the Brainstem
13 mars 2023 08h00 HE
|
Oncotelic Therapeutics, Inc.
-The TGFβ1 and TGFβ3 isoforms are predictive --Validation of TGFβ2 as therapeutic target AGOURA HILLS, Calif., March 13, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC)...
An Impressive Start For The 2023 Washington, D.C. Auto Show
24 janv. 2023 10h00 HE
|
Washington, D.C. Auto Show
Washington, D.C., Jan. 24, 2023 (GLOBE NEWSWIRE) -- The 2023 Washington, D.C. Auto Show opened last Thursday to policy leaders, automotive experts, and media partners during the highest attended...
The Washington, D.C. Auto Show and Washington Area Hyundai Dealers Team up to Support Georgetown Lombardi and Children’s National Hospital Through “Hyundai Hands On Hope” Contest
18 janv. 2023 15h48 HE
|
Washington, D.C. Auto Show
Washington, D.C., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Washington Area Hyundai Dealers to Donate $100,000 Total to Georgetown Lombardi and Children’s National to Fund Pediatric Cancer ResearchSix...
Qualigen Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule
12 déc. 2022 08h30 HE
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for...
Dawson Knox and For Bare Feet Launch Second Annual Knox Sox Campaign
29 sept. 2022 11h00 HE
|
For Bare Feet
BUFFALO, N.Y., Sept. 29, 2022 (GLOBE NEWSWIRE) -- For Bare Feet has partnered with Buffalo Bills TE Dawson Knox as the sock provider for year two of the Knox Sox campaign, benefitting P.U.N.T....
Five Below Teams Up With Alex’s Lemonade Stand Foundation To Raise More Than $1.5 Million for Pediatric Cancer Research
07 juil. 2022 10h30 HE
|
Five Below, Inc.
PHILADELPHIA, PA, July 07, 2022 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE), the trend-right, extreme-value brand for tweens, teens and beyond, is thrilled to announce that the Company’s...
AeroPress, Inc. Announces Winner of $100,000 Cookies for Kids’ Cancer Innovative Translational Research Award
01 mars 2021 11h23 HE
|
AeroPress, Inc.
Palo Alto, California, March 01, 2021 (GLOBE NEWSWIRE) -- AeroPress, Inc., based in Palo Alto, California, announces the winner of the inaugural $100,000 Innovative Translational Research Award to a...
Autolus Announces Data Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
03 oct. 2019 09h08 HE
|
Autolus Therapeutics plc
LONDON, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...